List of insiders holdings for CytomX Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses |
2024-11-14 16:26:32 | 8,089,795 0 |
8,089,795 | Form 13G |
2 | SHANNON TIMOTHY M Director |
2016-12-01 14:35:01 | 448 3,244,381 |
3,244,829 | Form 4 |
3 | McCarthy Sean A. CEO |
2025-03-20 16:34:40 | 995,195 93,158 |
1,088,353 | Form 4 |
4 | Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT CO Deerfield Special Situations Fund L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Possible Member of 10% Group 10% Owner |
2015-10-14 12:37:56 | 946,024 0 |
946,024 | Form 13G |
5 | Hadley Harbor Master Investors (Cayman) L.P. 10% Owner |
2015-10-14 15:36:21 | 749,055 0 |
749,055 | Form 4 |
6 | Goeltz II Robert C. Chief Financial Officer |
2017-05-16 16:57:43 | 323,325 0 |
323,325 | Form 4 |
7 | BELVIN MARCIA SVP, Chief Scientific Officer |
2025-03-20 16:31:34 | 248,636 0 |
248,636 | Form 4 |
8 | THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC LEVIN MARK J STARR KEVIN P TEPPER ROBERT I 10% Owner |
2019-02-13 16:07:03 | 227,653 0 |
227,653 | Form 13G |
9 | Ogden Christopher Chief Financial Officer |
2025-03-20 16:33:49 | 201,026 0 |
201,026 | Form 4 |
10 | Chu Yu-Waye Chief Medical Officer |
2025-03-20 16:32:56 | 135,725 0 |
135,725 | Form 4 |
11 | Landau Jeffrey B Chief Business Officer |
2024-08-22 18:01:51 | 119,056 7,680 |
126,736 | Form 4 |
12 | ROWLAND LLOYD A General Counsel |
2025-03-20 16:32:22 | 120,594 0 |
120,594 | Form 4 |
13 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. |
2020-02-19 18:41:18 | 120,000 0 |
120,000 | Form 4 |
14 | RAY DEBANJAN Chief Financial Officer |
2019-01-29 18:57:09 | 90,000 0 |
90,000 | Form 4 |
15 | HUMPHREY RACHEL Chief Medical Officer |
2019-01-29 19:00:03 | 90,000 0 |
90,000 | Form 4 |
16 | LADD CYNTHIA J Senior VP and General Counsel |
2017-01-27 13:52:15 | 84,000 0 |
84,000 | Form 4 |
17 | Peterson Amy C. EVP, Chief Development Officer |
2023-03-20 18:43:26 | 58,433 0 |
58,433 | Form 4 |
18 | Campoy Carlos Chief Financial Officer |
2023-03-20 18:43:33 | 38,224 0 |
38,224 | Form 4 |
19 | Young Matthew P. Director |
2024-05-17 17:36:18 | 38,000 0 |
38,000 | Form 4 |
20 | Ashworth Alan Director |
2024-05-17 17:31:09 | 38,000 0 |
38,000 | Form 4 |
21 | Gilbert Halley E Director |
2024-05-17 17:32:25 | 38,000 0 |
38,000 | Form 4 |
22 | Jones Elaine V Director |
2024-05-17 17:33:14 | 38,000 0 |
38,000 | Form 4 |
23 | Meyers James R Director |
2024-05-17 17:34:02 | 38,000 0 |
38,000 | Form 4 |
24 | Mohindru Mani Director |
2024-05-17 17:34:38 | 38,000 0 |
38,000 | Form 4 |
25 | Su Zhen Director |
2024-05-17 17:36:07 | 38,000 0 |
38,000 | Form 4 |
26 | Knifsend Robin Principal Accounting Officer |
2020-02-21 12:34:43 | 34,000 0 |
34,000 | Form 4 |
27 | HANNAH ALISON L. Chief Medical Officer |
2022-07-21 16:09:25 | 31,898 0 |
31,898 | Form 4 |
28 | GLUCK FREDERICK W Director |
2022-06-17 16:05:38 | 25,000 0 |
25,000 | Form 4 |
29 | SCARLETT JOHN A Director |
2021-06-17 18:46:39 | 20,000 0 |
20,000 | Form 4 |
30 | Fuchs Charles S. Director |
2020-06-17 17:06:48 | 20,000 0 |
20,000 | Form 4 |
31 | Huh Hoyoung Director |
2018-06-15 17:51:36 | 14,000 0 |
14,000 | Form 4 |
32 | McCourt Marion Director |
2017-06-22 13:58:17 | 14,000 0 |
14,000 | Form 4 |
33 | Exter Neil Director |
2017-06-22 13:56:58 | 14,000 0 |
14,000 | Form 4 |
34 | Canaan IX L.P. Canaan Partners IX LLC Director |
2017-07-07 08:40:32 | 0 0 |
0 | Form 13G |